跳转至内容
Merck
CN
  • Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression.

Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression.

Oncoimmunology (2015-09-26)
Wendy Wj Unger, Christian T Mayer, Steef Engels, Christina Hesse, Maurizio Perdicchio, Franz Puttur, Ingeborg Streng-Ouwehand, Manja Litjens, Hakan Kalay, Luciana Berod, Tim Sparwasser, Yvette van Kooyk
摘要

Therapeutic vaccinations against cancer are still largely ineffective. Major caveats are inefficient delivery of tumor antigens to dendritic cells (DCs) and excessive immune suppression by

材料
货号
品牌
产品描述

Sigma-Aldrich
佛波醇12-十四酸酯13-乙酸酯, ≥99% (TLC), film or powder
Sigma-Aldrich
DAPI, for nucleic acid staining
Sigma-Aldrich
PMA, for use in molecular biology applications, ≥99% (HPLC)
Sigma-Aldrich
异丙醇, ≥99.7%, FCC, FG
Sigma-Aldrich
2-丙醇, BioUltra, for molecular biology, ≥99.5% (GC)
Sigma-Aldrich
2-丙醇, electronic grade, 99.999% trace metals basis
Sigma-Aldrich
佛波醇12-十四酸酯13-乙酸酯, synthetic, ≥98.0% (TLC)
Sigma-Aldrich
2-丙醇, anhydrous, 99.5%
Sigma-Aldrich
2-丙醇, for molecular biology, BioReagent, ≥99.5%
Sigma-Aldrich
布雷菲德菌素 A, from Penicillium brefeldianum, Ready Made Solution, 10 mg/mL in DMSO
Sigma-Aldrich
溴化乙锭单叠氮化物, ≥95% (HPLC), solid